s p o n s o r e d   l i n k s

Innovation News

A milestone in the global cell analysis: 40 years of flow cytometry

2009 is the year of the 40th anniversary since the introduction of the first global flow cytometer based on fluorescence, the ICP 11.

Currently, the German biotechnology company Partec celebrates anniversary in Saxonia State Wackerbarth Vineyard Castle near Dresden. For the festive ceremony, the director Roland Göhde receive 100 guests from the scientific, economic and political.


2009 is the year of the 40th anniversary since the introduction of the first global flow cytometer based on fluorescence, the ICP 11.

Currently, the German biotechnology company Partec celebrates anniversary in Saxonia State Wackerbarth Vineyard Castle near Dresden. For the festive ceremony, the director Roland Göhde receive 100 guests from the scientific, economic and political.

Amira Pharmaceuticals presents data on the agenda of LPA1 receptor antagonist

Amira Pharmaceuticals, Inc. announced it will present preclinical data on its program of LPA1 receptor antagonist on June 30, 2009 in the summer research conference of the Federation of American Societies for Experimental Biology (FASEB) held in Carefree, Arizona.

The LPA1 receptor is part of the phosphatidic acid path / lisofosfatidilcolina, which among other things is associated with the communication from cell to cell. In recent studies, it has been shown to play a role in fibrotic disease, particularly idiopathic pulmonary fibrosis (IPF).


Amira Pharmaceuticals, Inc. announced it will present preclinical data on its program of LPA1 receptor antagonist on June 30, 2009 in the summer research conference of the Federation of American Societies for Experimental Biology (FASEB) held in Carefree, Arizona.

The LPA1 receptor is part of the phosphatidic acid path / lisofosfatidilcolina, which among other things is associated with the communication from cell to cell. In recent studies, it has been shown to play a role in fibrotic disease, particularly idiopathic pulmonary fibrosis (IPF).

Amira Pharmaceuticals presents data on the agenda of LPA1 receptor antagonist

Amira Pharmaceuticals, Inc. announced it will present preclinical data on its program of LPA1 receptor antagonist on June 30, 2009 in the summer research conference of the Federation of American Societies for Experimental Biology (FASEB) held in Carefree, Arizona.

The LPA1 receptor is part of the phosphatidic acid path / lisofosfatidilcolina, which among other things is associated with the communication from cell to cell. In recent studies, it has been shown to play a role in fibrotic disease, particularly idiopathic pulmonary fibrosis (IPF).


Amira Pharmaceuticals, Inc. announced it will present preclinical data on its program of LPA1 receptor antagonist on June 30, 2009 in the summer research conference of the Federation of American Societies for Experimental Biology (FASEB) held in Carefree, Arizona.

The LPA1 receptor is part of the phosphatidic acid path / lisofosfatidilcolina, which among other things is associated with the communication from cell to cell. In recent studies, it has been shown to play a role in fibrotic disease, particularly idiopathic pulmonary fibrosis (IPF).

ERYtech Pharma presents new breakthrough in the treatment of sickle-cell anemia

ERYtech Pharma has been chosen to present the initial results obtained with its preclinical product GR-ARA1 on sickle cell anemia at the 50th annual congress of the American Society of Hematology (ASH), to be held in San Francisco (United States) from 6 to Dec. 9, 2008.

Sickle cell disease is a genetic disease characterized by the presence of sickle red blood cells in patients suffering from hypoxia (about 100,000 cases in Europe and North America).


ERYtech Pharma has been chosen to present the initial results obtained with its preclinical product GR-ARA1 on sickle cell anemia at the 50th annual congress of the American Society of Hematology (ASH), to be held in San Francisco (United States) from 6 to Dec. 9, 2008.

Sickle cell disease is a genetic disease characterized by the presence of sickle red blood cells in patients suffering from hypoxia (about 100,000 cases in Europe and North America).

Last Content



All Times: ozonation wastewater power point, levenspiel. engineering flow and heat exchange, ppt on importance of chemical engineering, powerpoint themes chemical engineering, ppt procese de membrana, ppt on importance of chemical engineering , filter scrubber aerosal methane wastewater, chemical engineers req in jubail?, property of fluids [pdf], how to design distillation column for styrene production, boiler operations engineering questions and answers free boo down load, the alternatives of desalination process, chemical equations in sewage, dairy manufacturing process animated ppt, air pollution control a design approach, solution manual, free download, caracteristic of polimer.ebooks.pdf, molecular thermodynamics of fluid-phase equilibria solution manual torrent, solution manual chemical engineering kinetics j.m smith, water pollution filetype.swf, ppt.petrochemical industry, plant-design-and-economics-for-chemical-engineer solution free download, d.m plant reverse osmosis,ion absorber ppt presentation , engineeing mechanics, macabe smith, introduction to material and energy balances rapidshare, tesoro refinery process engineer position, reverse osmosis schematic design, torrents ebooks engineering chemical, primary secondary and tertiary treatment of wastewaterpdf, water treatment systemsppt, spreadsheet templates for chemical engineers, nanofiltration simulation softwaredownload, elements of chemical reaction engineering 4th edition solution manual, polymer testing methods books free download pdf, free chemical industrial safety ppts, ppt chemical themes, thermodynamic modular simulation principles, ammonia ammonia process filetype:ppt, primary,secondary,tertiory wastewater treatment , ebooks ammonia, more...